Introduction {#S1}
============

Energy homeostasis plays a critical role in maintaining the survival and function of cells. In 1967, Atkinson proposed using the adenylate system \[ATP (adenosine 5′ triphosphate) + ADP (adenosine diphosphate) + AMP (adenosine monophosphate)\] to estimate cellular energy levels ([@B4]; [@B5]). ATP acts as a high-energy bond donor, and ATP can be broken down into ADP and AMP, which is accompanied by the release of energy. Increased levels of cellular ADP and/or AMP are indicators of decreased energy status. AMP-activated protein kinase (AMPK) is the dominant energy sensor in eukaryotic cells ([@B26]). As a master regulator of metabolism, AMPK is proposed to regulate energy homeostasis ([@B28]), cell growth ([@B64]), autophagy ([@B64]), and mitochondrial biology ([@B33]). Recent advances in research have proposed that the biological effects of AMPK can be tissue- and/or cell type-specific. Hypothalamic AMPK modulates the energy balance of the whole body via the regulation of food intake ([@B54]). In T cells, AMPK regulates cell migration and determines CD8+ T cell fate (differentiation into effector or memory CD8+ T cells) ([@B20]). However, the functions of AMPK in the mammary gland are still unclear.

The mammary gland is a unique organ for the secretion of milk. The mammary gland contains not only the epithelial cells but also the stromal compartment (also known as connective tissue or fat pad) ([@B32]). Mammary epithelium includes luminal and secretory cells that are involved in milk production during lactation period. The primary components of the mammary stroma are adipocytes, but it also contains fibroblasts, blood vessels and neurons. Milk directly regulates the early growth and health of neonates. The main components of milk are carbohydrates, lipids, and proteins with small proportions of minerals and vitamins. Colostrum is the milk secreted shortly after fallowing and consists a higher level of immunoglobulins (IgG, IgM, and IgA). These immunoglobulins are involved in the establishment of passive immunity for neonates. The energy requirements and mobilization in the mammary gland are high and very complicated. During lactation, energy is not only consumed by the mammary gland to maintain its basic metabolism but also largely used for milk production ([@B76]). In this review, we summarized recent advances in the understanding of the mechanism by which AMPK regulates milk production and mammary gland biology. Understanding the functions of AMPK and its downstream targets in the mammary gland will contribute to the development of nutritional or drug-related strategies for improving mammary gland health and promoting milk production.

AMP-Activated Protein Kinase {#S2}
============================

AMP-activated protein kinase exists as a heterotrimer, which consists of one catalytic subunit (α) and two regulatory subunits (β and γ) ([@B89]). There are multiple isoforms of these AMPK subunits, including α1, α2, β1, β2, γ1, γ2, and γ3 ([@B27]). AMPKα1 is dominantly expressed in the mammary gland ([@B72]), while AMPK α2 and γ3 are undetectable ([@B63]). This evidence indicates that the expression of AMPK subunits could be tissue dependent.

The canonical mechanism by which AMPK is activated (phosphorylation at Thr172) relies on increased levels of ADP, AMP or Ca^2+^. LKB1 (liver kinase B1) and CaMKKβ (Ca^2+/^calmodulin-activated protein kinase kinase-β) are the primary upstream kinases of AMPK ([@B29], [@B30]). During conditions of energy deprivation, ADP can directly bind to the γ regulatory subunit of AMPK ([@B28]). In even more severe situations, ADP is converted to AMP, which leads to a conformational change in AMPK and increases its activity by approximately 10-fold ([@B28]). This conformational change also protects AMPK from being dephosphorylated and ensures its activation. In addition, increased levels of Ca^2+^ can directly regulate AMPK activity through CaMKKβ and in manner that is independent of the level of ADP or AMP ([@B30]). In the human mammary gland, activated LKB1 and CaMKKβ are also reported to increase the activity of AMPK ([@B37]; [@B14]).

In addition to ADP, AMP and Ca^2+^, AMPK can also be activated by non-canonical signals, such as low oxygen ([@B59]), reactive oxygen species (ROS) ([@B3]; [@B17]) and DNA damage ([@B43]; [@B77]). When oxygen is limited, nutrients are not completely oxidized, which limits the production of ATP ([@B16]). ROS are proposed to regulate AMPK through two different pathways: (1) oxidation of the two conserved Cys residues in the AMPK α subunit ([@B3]) and (2) activation of ataxia telangiectasia mutated (ATM), which is a phosphoinositide 3 kinase-like kinase (PIKK) that triggers the activation of AMPK ([@B17]). DNA damage-induced activation of AMPK is also ATM-dependent ([@B79]; [@B84]).

Activation of AMPK in the Mammary Gland {#S3}
=======================================

Negative energy balance (NEB) is widely observed in swine and cow production, especially during lactation. Elevated ADP or AMP is often associated with a NEB ([Figure 1](#F1){ref-type="fig"}). The feed intake of primiparous sows usually fails to meet the nutritional requirements for fetal growth and milk production, leading to the mobilization of protein and fat reserves in the body. Similarly, the peak lactation period of cows generally occurs 4--6 weeks after delivery, but the dry matter intake (DMI) does not reach its maximum until 8--10 weeks after delivery ([@B6]). Thus, during this period, the energy intake in dairy cows is not able to meet the demand for milk production (especially in high-yielding cows). AMPK signaling in the mammary gland is highly active during this period, which results in a 15--20% decrease in milk production in sows and cows ([@B18]; [@B87]). *In vitro* experiments also demonstrated that AMPK is significantly activated in mammary epithelial cells during energy deprivation (cells cultured without glucose or amino acids) ([@B94]).

![Negative energy balance induces the activation of mammary AMPK through the canonical pathway: during lactation, decreased maternal feed intake usually fails to meet the requirement for milk secretion and leads to a negative energy balance. Elevated ADP or AMP in the mammary gland is associated with a negative energy balance and promotes AMPK activity. AID, auto-inhibitory domain; CAMKK2, calmodulin dependent protein kinase kinase 2; CBM, carbohydrate-binding module; CBS, cystathionine-beta-synthase; LKB1, liver kinase B1.](fcell-08-00530-g001){#F1}

In addition to NEB, heat stress is reported to negatively regulate mammary gland development and milk production in cows ([@B82]) and sows ([@B73]). Intriguingly, recent findings indicate that heat stress triggers the activation of AMPK in the mammary gland. In the murine mammary gland, the AMPK signaling pathway is significantly upregulated by heat stress ([@B24]). In a transcriptomic study of the bovine mammary gland, AMPK signaling was the most highly activated pathway in response to heat stress ([@B21]). The non-canonical pathway could be a potential link between heat stress and AMPK ([Figure 2](#F2){ref-type="fig"}). First, under heat stress, ROS are increased and accumulate in the bovine mammary gland ([@B50]). Activation of AMPK decreases the production of ROS ([@B19]) and enhances the antioxidant capacity ([@B23]) of the mammary gland. Second, oxygen uptake is significantly decreased in sows during heat stress ([@B9]). Third, heat stress induces DNA damage in the mammary gland ([@B66]). In addition, heat stress also decreases feed intake in mammals, which indirectly triggers a decrease in energy intake and subsequently increases the levels of ADP and AMP. Therefore, heat stress can coordinately regulate AMPK through canonical and non-canonical pathways in the mammary gland.

![Heat stress induces the activation of mammary AMPK through canonical and non-canonical pathways: heat stress increases ROS, decreases blood oxygen, and alters DNA integrity, which further activates AMPK (non-canonical pathway). Additionally, the decreased feed intake (increased ADP and AMP) caused by heat stress also activates AMPK. ROS, reactive oxygen species; AID, auto-inhibitory domain; ATM, ataxia telangiectasia-mutated gene; CAMKK2, calmodulin dependent protein kinase kinase 2; CBM, carbohydrate-binding module; CBS, cystathionine-beta-synthase; LKB1, liver kinase B1.](fcell-08-00530-g002){#F2}

AMPK Regulates Milk Synthesis {#S4}
=============================

Milk Fat {#S4.SS1}
--------

The process of milk fat synthesis in different species has been previously well summarized ([@B7]; [@B68]; [@B96]). Briefly, the process includes *de novo* fatty acid (FA) synthesis, FA uptake, FA activation, FA intracellular transport, FA elongation, FA desaturation, triacylglycerol (TAG) synthesis and lipid droplet formation. The FAs used for milk fat synthesis are either derived from blood circulation or are originally synthesized in the mammary gland. AMPK is a critical sensor that regulates fat metabolism in the mammary gland ([Figure 3](#F3){ref-type="fig"}). It has been reported that AMPK activators 5-aminoimidazole-4-carboxamide 1-β-[D]{.smallcaps}-ribofuranoside (AICAR) and A-769662 (A76) are reported to inhibit fat synthesis in the bovine mammary gland ([@B63]; [@B39]).

![AMPK regulates mammary milk fat synthesis: AMPK phosphorylates and inactivates ACC1 and ACC2. ACC1 is a cytosolic protein that converts acetyl-CoA to malonyl-CoA during *de novo* fatty acid synthesis. ACC2 is associated with mitochondria and regulates mitochondrial fatty acid oxidation through the inhibition of CPT1 by malonyl-CoA. AMPK inhibits the transcriptional activity of SREBP-1c through the phosphorylation of SERBP1c at Ser372, which further decreases the expression of ACC1, FAS, SCD and FABP3, which participate in fatty acid synthesis. ACC1, acetyl-coA carboxylase 1; ACC2, acetyl-coA carboxylase 2; AID, auto-inhibitory domain; CBS, cystathionine-beta-synthase; CPT1, carnitine palmitoyl transferases 1; FABP3, fatty acid binding protein 3; FAS, fatty acid synthase; LXRα, liver X receptor α; SCD, stearoyl-CoA desaturase; SFA, saturated fatty acid; SRE, sterol-regulatory element; SREBP1c, sterol-regulatory element binding protein 1c; TAG, triacylglyceride; USFA, unsaturated fatty acid.](fcell-08-00530-g003){#F3}

AMPK phosphorylates its downstream proteins at Ser/Thr residues (recognition motifs of AMPK: Φ(X,β)XXS/TXXXΦ) (Φ, hydrophobic; β, basic) ([@B15]). Acetyl-coA carboxylase (ACC) is a rate-limiting enzyme in fatty acid metabolism. It is one of the primary downstream pathways of AMPK. AICAR activates AMPK and inhibits ACC1 in goat mammary epithelial cells ([@B95]). The coding and amino acid sequences of ACC were first identified in the murine mammary gland in 1988 ([@B55]). Two isoforms of ACC have been identified in animals, namely, ACC1 (ACACA) and ACC2 (ACACB). ACC1 is a cytosolic protein that catalyzes the conversion of acetyl-CoA to malonyl-CoA during *de novo* FA synthesis ([@B1]). ACC2 is associated with the outer membrane of mitochondria. The malonyl-CoA produced by ACC2 regulates mitochondrial fatty acid oxidation through the inhibition of carnitine palmitoyltransferase 1 (CPT1) ([@B1]). ACC is highly expressed in the mammary gland during the lactation period ([@B56]). The dominant isoform of ACC in the mammary gland varies among different animals. In the rat mammary gland, the main type of ACC is ACC2, while ACC1 is mainly expressed in white adipose tissue ([@B56]; [@B71]). However, both ACC1 and ACC2 are highly expressed in the murine mammary gland ([@B80]). Similarly, ACC1 ([@B57]) and ACC2 ([@B69]) are also detected in the porcine mammary gland and are upregulated during lactation. In dairy cows, ACC1 is considered a critical regulator of fatty acid synthesis in the mammary gland ([@B60]; [@B81]). Short-term energy deprivation induces ACC phosphorylation and inhibits fatty acid synthesis in bovine mammary gland epithelial cells ([@B63]). Thus, AMPK is proposed to control the switch between lipogenesis and lipid oxidation through the phosphorylation or dephosphorylation of ACCs.

The other critical downstream target of AMPK is sterol regulatory element-binding protein 1c (SREBP1c), which is a lipogenic transcription factor. Previously, AMPK activation (triggered by AICAR or A-769662) was reported to decrease the mRNA expression of lipogenic genes, including FAS and FABP3 in the bovine mammary gland ([@B95]; [@B39]). AMPK inhibits the transcriptional activity of sterol regulatory element binding protein-1c (SREBP-1c) through the phosphorylation of SERBP1c at Ser372 ([@B53]). SREBP1c was initially identified as a regulator of lipogenesis in the liver ([@B35]). Subsequently, SREBP1c has been proposed to regulate milk fat synthesis in cows ([@B51]), goats ([@B91]), and swine ([@B13]). SREBP-1c binds to the promoter of lipogenic genes and increases their mRNA expression ([@B34]). The core promoter region of SREBP1c in the goat mammary gland is located from −395 to +1 bp upstream of the transcriptional start site and includes liver X receptor α (LXRα) binding elements and sterol regulatory elements ([@B90]). In bovine mammary epithelial cells, the overexpression of SREBP1c significantly increases the expression of ACC1, FAS (fatty acid synthase), SCD (stearoyl-CoA desaturase) and FABP3 (fatty acid-binding protein) ([@B51]). Consistently, the knockdown of SREBP1c decreases the expression of lipogenic genes ([@B51]). In goat mammary epithelial cells, SREBP1c overexpression upregulates numerous genes that are responsible for *de novo* fatty acid synthesis and fatty acid transportation ([@B91]). In the murine mammary gland, the knockdown of SREBP1c decreases the expression of FAS and SCD2 ([@B74]). Thus, AMPK can indirectly control transcription of lipogenic genes in the mammary gland through the phosphorylation of SREBP1c.

In addition to ACC and SREBP-1c, AMPK also regulates milk fat synthesis through adipose triglyceride lipase (ATGL) and TBC1 domain family member 1 (TBC1D1). ATGL mainly regulates the first step of the lipid lipolysis process. ATGL is a downstream target of peroxisome proliferator-activated receptor γ (PPARγ) ([@B78]) but not of SREBP1c ([@B91]). Recently, AMPK was reported to activate ATGL through the phosphorylation of Ser406 ([@B2]; [@B48]). In the goat mammary gland, ATGL is considered an important enzyme that regulates milk fat synthesis (59). In contrast to ATGL, TBC1D1 has been shown to regulate the translocation of glucose transporter 4 (GLUT4), which is an important insulin-sensitive transporter of glucose ([@B75]). AMPK regulates the activity of TBC1D1 through the phosphorylation of Ser237 and Thr596 ([@B70]). Interestingly, a whole genome resequencing study in cows showed that TBC1D1 expression is correlated with milk fat percentage ([@B44], [@B45]).

It is worth noting that some potential targets of AMPK might also regulate milk fat synthesis in the mammary gland. For example, AMPK increases the activity of Coactivator 1 alpha (PGC-1α) through the phosphorylation of Thr177 and Ser538 ([@B42]). PGC-1α is a transcriptional coactivator of transcription factor PPARγ ([@B25]). In the liver, PGC-1α is proposed to regulate fatty acid β-oxidation through PPARγ ([@B40]). The other potential target protein is Liver X receptors (LXRs), which regulates the expression of SREBP1c and the process of lipogenesis. In the liver, AMPK is found to inhibit the ligand-induced LXR activity on Srebp-1c promoter ([@B93]). Intriguingly, recent studies reported that the activation of LXRs also increases the fatty acid synthesis in the mammary gland ([@B62]; [@B67]). To date, PGC-1α and LXR have been identified as downstream targets of AMPK in the liver. It would be interesting to know whether these mechanisms could be validated in the mammary gland as well.

Milk Protein {#S4.SS2}
------------

Milk proteins, such as caseins and whey proteins, are important sources of nutrition for neonates. Colostrum contains immunoglobulins, such as IgG, IgM, and IgA, which are important to establish the early immunity of neonates. The amino acids used for milk protein synthesis are transported via a complicated transportation system ([@B97]). The process of milk protein synthesis requires a significant amount of energy ([@B65]). The master regulator of protein synthesis is mammalian target of rapamycin complex 1 (mTORC1). Dietary energy deprivation activates AMPK and inhibits mTORC1 in the rat mammary gland ([@B46]). Similarly, in bovine mammary epithelial cells, energy deprivation increases the phosphorylation of AMPK by inhibiting the mTORC1 signaling pathway ([@B10]). Glucose deprivation in bovine mammary epithelial cells leads to the downregulation of the mRNA expression of Casein Alpha S1 (CSN1S1), CSN2 and CSN3, which encode a~s1~-casein, β-casein and κ-casein, respectively ([@B94]). However, glucose promotes αS1-casein and β-casein protein synthesis in the bovine mammary gland ([@B86]).

mTORC1 is a master regulator of anabolic and catabolic metabolism in cells ([@B36]). More specifically, mTORC1 participates in the regulation of gene transcription ([@B61]), protein translation ([@B58]), and apoptosis ([@B83]). Eukaryotic initiation factor 4E binding protein (4EBP1) and ribosomal protein S6 kinase 1 (S6K1), which mainly regulate protein translation, are two independent downstream regulators of mTORC1 ([@B47]). Two independent pathways have been previously reported to inhibit mTOR activity through AMPK activation ([Figure 4](#F4){ref-type="fig"}). First, AMPK inhibits TSC2 (Tuberin 2, which is a negative regulator of mTORC1) through the phosphorylation of Ser1345 ([@B41]). Second, AMPK inhibits Raptor (a component of mTORC1) through the phosphorylation of Ser792 ([@B12]). In the mammary gland, AMPK is also reported to regulate the phosphorylation of TSC2 ([@B41]) and Raptor ([@B10]).

![AMPK regulates mammary milk protein synthesis: mTORC1 is the master regulator that controls milk protein synthesis in the mammary gland through 4EBP1 and S6K1. AMPK directly inhibits mTORC1 through the phosphorylation of raptor at Ser 792. AMPK also decreases mTOR activity through the phosphorylation of TSC2 (a negative mTORC1 regulator) at Ser1345. The genes encoding a~s1~-casein (CSN1S1), β-casein (CSN2) and κ-casein (CSN3) are also decreased with the activation of AMPK. 4EBP1, eukaryotic initiation factor 4E binding protein 1; AID, auto-inhibitory domain; CBS, cystathionine-beta-synthase; eEF2, eukaryotic elongation factor 2; eEF2K, eukaryotic elongation factor 2 kinase; eIF4A, eukaryotic initiation factor 4A; eIF4E, eukaryotic initiation factor 4E; eIF4G, eukaryotic initiation factor 4G; Raptor, regulatory associated protein of TOR; Rheb, ras homolog enrichedin brain; S6K1, s6 kinase 1; TSC2, tuberin 2; mTOR, mammalian target of rapamycin; mTORC1, mammalian target of rapamycin complex 1; mLST8, mammalian ortholog of LST8.](fcell-08-00530-g004){#F4}

The other potential downstream target of AMPK in the regulation of protein synthesis is eukaryotic translation elongation factor 2 kinase (eEF2K), which is a negative regulator of protein elongation ([@B49]). As a downstream target of eEF2K, eEF2 is significantly increased during the lactation period in the bovine mammary gland ([@B8]). This observation suggests that eEF2K is a crucial regulator of milk synthesis during lactation.

Milk Lactose {#S4.SS3}
------------

In the mammary gland, 55--70% of glucose is used for lactose synthesis ([@B22]). Glucose acts as a substrate and provides energy for lactose synthesis. Compared with studies regarding AMPK signaling during milk protein and fat synthesis, studies regarding AMPK signaling during lactose production are limited. This gap in the literature might be because the mammary gland is the only model in which lactose synthesis can be studied. In addition, technical challenges make it difficult to induce high levels of lactose synthesis in the mammary epithelial model *in vitro*. The mammary lactose synthesis pathway has been previously summarized ([@B96]). Briefly, glucose and UDP-galactose (derived from glucose) are synthesized into lactose in the Golgi bodies. Some evidence indicates that lactose synthesis is inhibited by AMPK activation. AMPK activation (stimulated by A-769662) is found to decrease the rate of lactose synthesis in the bovine mammary gland ([@B39]). Interestingly, activated AMPK increases GLUT1 mRNA expression and glucose uptake in the goat mammary gland ([@B95]). AMPK-induced increased GLUT1 expression occurs through the phosphorylation of thioredoxin-interacting protein (TXNIP) at Ser308 ([@B88]). Although glucose is a critical source for lactose synthesis, the increase in GLUT1 does not indicate increased mammary lactose synthesis. Under energy deprivation conditions, increased cellular glucose is directly used to generate energy to maintain basic cellular function rather than to synthesize lactose. The detailed mechanism by which AMPK regulates the enzymes involved in lactose synthesis is still unclear and requires further research.

AMPK Regulates Mammary Gland Development {#S5}
========================================

The Janus kinase (Jak)-signal transducer and activator of transcription (Stat) signaling pathway is critical for mammary gland development ([@B31]; [@B85]). Either glucose or amino acid deprivation activates AMPK and simultaneously decreases the Jak2/STAT5 signaling pathway in bovine mammary epithelial cells ([@B94]). Initially, it was proposed that Jak2/STAT5 is involved in alveologenesis and mammary epithelial cell maintenance ([@B85]; [@B11]). Recently, Jak2/STAT5 was also found to regulate milk protein synthesis through the regulation of casein translation ([@B92]). However, the evidence supporting a direct connection between AMPK and Jak2/STAT5 is still unclear and requires more study in the future.

AMPK Functions Beyond Milk Synthesis and Mammary Gland Development {#S6}
==================================================================

In addition to regulating milk production, recent evidence indicates that AMPK is involved in the regulation of other biological functions of mammary glands ([Figure 5](#F5){ref-type="fig"}); these other biological functions include: (1) inhibiting epithelial cell proliferation and decreasing cell cycle progression in the mammary gland ([@B86]); (2) regulating circadian clock protein expression in the mammary gland ([@B38]); (3) relieving oxidative stress in the mammary gland ([@B23]); and (4) increasing autophagy and enhancing the renewal of the mammary gland ([@B52]).

![A working model of how AMPK regulates milk secretion and mammary gland function. ACC1, acetyl-coA carboxylase 1; ACC2, acetyl-coA carboxylase 2; SREBP1c, sterol regulatory element binding protein-1c; TSC2, tuberin 2. Solid circle indicates this function has been widely verified in the mammary gland. Dashed circle indicates this function still needs to be verified in the mammary gland.](fcell-08-00530-g005){#F5}

Conclusion and Outlook {#S7}
======================

To date, AMPK appears as a critical sensor in the mammary gland that detects nutrient fluctuations and environmental changes. Energy deprivation and heat stress are two major elements involved in the activation of AMPK in the mammary gland. AMPK regulates milk production (fat, protein, and lactose) and mammary gland biology (development and proliferation) through the regulation of transcription and post-translational modifications.

To the best of our knowledge, the existing evidence regarding the effects of the AMPK pathway on the mammary gland was mainly obtained under conditions of energy deprivation (amino acid or glucose deprivation). It is important to understand the function of AMPK and its related signaling pathways in the mammary gland using tissue-specific knockout mice. Future studies using AMPK-specific agonists and antagonists may also extend our understanding of AMPK signaling in the mammary gland. To date, most research studying normal mammary gland were performed in cows, mice and sows, rather than humans. Thus, it is of great importance to investigate the functions of AMPK in humans.

The most direct way to inactivate AMPK is to increase energy intake. However, according to production experience, it is very challenging to increase energy intake during the lactation period in mammals due to the limited gut volume. Thus, it would be interesting to determine whether an AMPK antagonist could rescue the decrease in milk production caused by energy deprivation and/or heat stress. The identification of novel nutritional and pharmacological inhibitors of AMPK, which can be widely and safely used as food or feed additives in mammalian diets, remains a major challenge.
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